IN2012DN05279A - - Google Patents

Info

Publication number
IN2012DN05279A
IN2012DN05279A IN5279DEN2012A IN2012DN05279A IN 2012DN05279 A IN2012DN05279 A IN 2012DN05279A IN 5279DEN2012 A IN5279DEN2012 A IN 5279DEN2012A IN 2012DN05279 A IN2012DN05279 A IN 2012DN05279A
Authority
IN
India
Prior art keywords
potential
methods
acid
nutritional compositions
nutritional
Prior art date
Application number
Inventor
Kevin Burke Miller
Zamzam Kabiry Roughead
Jennifer Rae Mager
Douglad Richard Bolster
Norman Alan Greenberg
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of IN2012DN05279A publication Critical patent/IN2012DN05279A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/185—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06F—ELECTRIC DIGITAL DATA PROCESSING
    • G06F17/00—Digital computing or data processing equipment or methods, specially adapted for specific functions
    • G06F17/10—Complex mathematical operations

Abstract

Nutritional compositions having the potential to reduce metabolic acid load and methods of making and using the nutritional compositions are provided. In an embodiment the present disclosure provides methods of selecting and administering nutritional compositions to patients. The methods may include modifications to calculating a metabolic acid potential of a nutritional composition calculating a base content of a nutritional composition and subtracting the base content from the acid content to determine a potential renal acid load ('PRAL') value. The present disclosure also provides computer implemented processes for predicting PRAL values.
IN5279DEN2012 2009-12-22 2010-12-21 IN2012DN05279A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US28892809P 2009-12-22 2009-12-22
US29668810P 2010-01-20 2010-01-20
US201061424070P 2010-12-17 2010-12-17
PCT/US2010/061444 WO2011087769A2 (en) 2009-12-22 2010-12-21 Nutritional compositions and methods for optimizing dietary acid-base potential

Publications (1)

Publication Number Publication Date
IN2012DN05279A true IN2012DN05279A (en) 2015-08-07

Family

ID=44304885

Family Applications (1)

Application Number Title Priority Date Filing Date
IN5279DEN2012 IN2012DN05279A (en) 2009-12-22 2010-12-21

Country Status (12)

Country Link
US (1) US20130129838A1 (en)
EP (1) EP2516007A2 (en)
JP (1) JP2013514812A (en)
CN (1) CN102753043A (en)
AU (1) AU2010341566A1 (en)
BR (1) BR112012018321A2 (en)
CA (1) CA2785262A1 (en)
IN (1) IN2012DN05279A (en)
MX (1) MX2012007300A (en)
RU (1) RU2012131125A (en)
SG (1) SG181619A1 (en)
WO (1) WO2011087769A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10016472B2 (en) 2012-06-11 2018-07-10 William J. Kraemer Methods of mitigating the negative effects of resistance exercise
WO2013188422A1 (en) * 2012-06-11 2013-12-19 Nu Science Laboratories, Inc. Nutritional products and methods of improving exercise performance
WO2014047497A1 (en) * 2012-09-21 2014-03-27 Abbott Laboratories Nutritional compositions including calcium beta-hydroxy-beta-methylbutyrate, protein and low levels of electrolytes
RU2615569C2 (en) * 2012-12-14 2017-04-05 Хилл'С Пет Ньютришн, Инк. Anti-ageing fodders for domestic animals
NZ711956A (en) 2013-03-08 2018-06-29 Axiom Foods Inc Rice protein supplements
US9820504B2 (en) 2013-03-08 2017-11-21 Axiom Foods, Inc. Rice protein supplement and methods of use thereof
US10271570B2 (en) 2013-08-15 2019-04-30 Nu Science Laboratories, Inc. Compositions for and methods of diet supplementation
WO2015069215A1 (en) 2013-11-05 2015-05-14 Hill's Pet Nutrition, Inc. Methods and compositions for improving kidney function
EP3273804A4 (en) * 2015-03-26 2018-08-15 Cambrooke Therapeutics, Inc. Aqueous ketogenic compositions
WO2018209131A1 (en) 2017-05-12 2018-11-15 Axiom Foods, Inc. Rice products and systems and methods for making thereof
IT202000008203A1 (en) * 2020-04-17 2021-10-17 D M F Dietetic Metabolic Food S R L NUTRITIONAL COMPOSITION FOR THE TREATMENT OF METABOLIC DISEASES

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4002204A1 (en) * 1990-01-26 1991-08-01 Westfalen Milchwerke DIET TABLE FOR PATIENTS WITH KIDNEY INSUFFICIENCY
US5733884A (en) * 1995-11-07 1998-03-31 Nestec Ltd. Enteral formulation designed for optimized wound healing
AT408416B (en) * 1996-07-19 2001-11-26 Norbert Fuchs PHARMACEUTICAL OR DIETETIC COMPOSITIONS
JP2000264844A (en) * 1999-01-11 2000-09-26 Otsuka Pharmaceut Factory Inc Nutritive composition for kidney disease patient
US6365218B1 (en) * 2000-02-04 2002-04-02 Abbott Laboratories Pediatric formula and methods for providing nutrition and improving tolerance
US20090137459A1 (en) * 2005-11-21 2009-05-28 Katry Inversiones, S.L. Food Product for Enteral or Oral Nutrition

Also Published As

Publication number Publication date
MX2012007300A (en) 2012-07-04
WO2011087769A2 (en) 2011-07-21
JP2013514812A (en) 2013-05-02
WO2011087769A3 (en) 2011-10-27
CA2785262A1 (en) 2011-07-21
EP2516007A2 (en) 2012-10-31
CN102753043A (en) 2012-10-24
BR112012018321A2 (en) 2019-09-24
US20130129838A1 (en) 2013-05-23
SG181619A1 (en) 2012-07-30
RU2012131125A (en) 2014-01-27
AU2010341566A1 (en) 2012-07-12

Similar Documents

Publication Publication Date Title
IN2012DN05279A (en)
MX342423B (en) 6 -benzylphenyl- 2 - sulfurterahydropyran-3, 4, 5 -triol derivatives as inhibitors of sodium -glucose cotrans porters 1 and 2 for use in diabetic patients.
MY163275A (en) Ibat inhibitors for the treatment of liver diseases
MX2021012876A (en) Novel anti-inflammatory agents.
GB2499924A (en) Public collaboration system
MX2012012928A (en) Compositions and methods of use for therapeutic low density lipoprotein -related protein 6 (lrp6) antibodies.
MX2009003658A (en) Bicyclic nitrogen-containing heterocyclic compounds for use as stearoyl coa desaturase inhibitors.
AU328418S (en) Cover for electronic equipment cabinet
MX2019005232A (en) Piperidin-4-yl azetidine derivatives as jak1 inhibitors.
TN2012000045A1 (en) Novel pyrimidine and triazine hepcidine antagonists
MX2012004525A (en) Compounds.
MX2010008875A (en) Combination of alpha 7 nicotinic agonists and antipsychotics.
MX2008008009A (en) Parenteral nutrition composition containing iron.
MX2011010451A (en) Oxadiazole derivatives.
Celik et al. Elevated adiponectin levels in patients with chronic heart failure: an independent predictor of mortality or a marker of cardiac cachexia?
NZ601552A (en) Component display processing method and user equipment
EP2024133A4 (en) Improved alloy and anode for use in the electrowinning of metals
MX2010000979A (en) Methods and compositions for treating autoimmune disease.
MX2009007429A (en) Pyridine compounds and their use as p2y12 antagonists.
MX2011007222A (en) Nutritional composition for infants.
WO2008155651A3 (en) Inositol for induction of ovulation
WO2010028336A3 (en) Fatty acid c16:1n7-palmitoleate a lipokine and biomarker for metabolic status
CY1107972T1 (en) DRY POWDER Sodium Contained Livothyroxine Spent Through the Nervous System
SG123796A1 (en) Low oxygen content alloy compositions
WO2007082048A3 (en) Ex vivo hyperpolarization of imaging agents